PDGFRB and colorectal carcinoma: The coordinated suppression of PDGFRB following CST4 knockdown provides experimental evidence supporting the bioinformatically identified CST4-PDGFRB signaling axis (Figure 3B), functionally validating its role in CRC pathogenesis.